ID   SEKI
AC   CVCL_3162
DR   BioSample; SAMN03472487
DR   cancercelllines; CVCL_3162
DR   Cell_Model_Passport; SIDM01344
DR   DepMap; ACH-001645
DR   JCRB; JCRB0620
DR   JCRB; JCRB1041
DR   JCRB; NIHS0312
DR   Wikidata; Q54952788
RX   CelloPub=CLPUB00112;
RX   CelloPub=CLPUB00113;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 4-5 days (CelloPub=CLPUB00112).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-001645).
CC   Omics: Genomics; Whole exome sequencing.
CC   Discontinued: JCRB; JCRB0620; probable.
CC   Discontinued: JCRB; NIHS0312; true.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): DepMap=ACH-001645; JCRB=JCRB1041
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,10.1,11 (JCRB=JCRB1041)
ST   D16S539: 9,11 (DepMap=ACH-001645)
ST   D18S51: 14,22
ST   D21S11: 33.2
ST   D3S1358: 16,17
ST   D5S818: 9,11
ST   D7S820: 9,12
ST   D8S1179: 10,11,12
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
RX   CelloPub=CLPUB00112;
RA   Shimoyama M., Ishihara K., Sakano T., Kimura K.;
RT   "A suspension cultured cell line established from a malignant
RT   melanoma.";
RL   Proc. Jpn. Cancer Assoc. 30:219.424-219.424(1971).
//
RX   CelloPub=CLPUB00113;
RA   Shimoyama M.;
RT   "Malignant melanoma, SEKI strain.";
RL   (In book chapter) Culture of human cancer cells; Oboshi S., Sugano H. (eds.); pp.208-215; Asakura-Shoten; Tokyo; Japan (1975).
//